FRENOVO Benzodiazepines (BZO) Rapid Test is a lateral flow, qualitative immunoassay. It is intended for qualitative detection of Oxazepam, a Benzodiazepines metabolite with a minimum detection concentration of 300 ng/ml in human urine samples, and for the preliminary screening detection of Benzodiazepines.